News
Local
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate News
Hot Property
eNewspaper
________________
Subscriptions
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
About Us
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Events
Advertising
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Jobs
CaregiverSD
Community papers
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Games, Puzzles, and Crossword
Crossword
Sudoku
Crossword
Sudoku
Obituaries
Death Notices
Place an obituary
Death Notices
Place an obituary
U-T En Español
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Privacy and Terms
Privacy
Terms
Advertising terms
Privacy
Terms
Advertising terms
Copyright © 2022, The San Diego Union-Tribune |
CA Notice of Collection
|
Do Not Sell My Personal Information
Sections
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate
Obituaries
eNewspaper
Newsletters
Show Search
Search Query
Submit Search
COVID-19
For subscribers
Phenomenal women
Latino life
Crossword
Sudoku
About Us
Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Diego Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Iovance Biotherapeutics, Inc. - Common Stock
(NQ:
IOVA
)
3.700
-0.310 (-7.73%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 10, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Iovance Biotherapeutics, Inc. - Common Stock
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
22
23
Next >
2 Beaten-Down Stocks With Incredible Upside Potential
↗
April 30, 2025
Via
The Motley Fool
Iovance Biotherapeutics Announces Participation in Upcoming Scientific Congresses
April 23, 2025
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
Iovance Biotherapeutics Stock Is Crashing. And Here's Why Things Could Get Even Worse This Year.
↗
April 23, 2025
Via
The Motley Fool
This Biotech Stock Could Be the Best Investment of the Decade
↗
April 19, 2025
There's an incredible growth story hiding in plain sight for investors who can look to the future.
Via
The Motley Fool
Forecasting The Future: 4 Analyst Projections For Iovance Biotherapeutics
↗
February 28, 2025
Via
Benzinga
Earnings Scheduled For February 27, 2025
↗
February 27, 2025
Via
Benzinga
What's Wrong With Iovance Biotherapeutics Stock?
↗
January 30, 2025
Via
The Motley Fool
Where Will Iovance Biotherapeutics Be in 5 Years?
↗
January 29, 2025
Via
The Motley Fool
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
April 18, 2025
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
Is Iovance Biotherapeutics a Millionaire-Maker?
↗
April 14, 2025
Via
The Motley Fool
4 Beaten-Down Stocks That Could Skyrocket by 50% to 543%, According to Wall Street
↗
April 07, 2025
Via
The Motley Fool
Traws Pharma Announces Management Updates
March 28, 2025
From
Traws Pharma, Inc.
Via
GlobeNewswire
Top 3 Health Care Stocks That Are Set To Fly This Month
↗
March 26, 2025
Via
Benzinga
1 Stock Worth Buying Near Its 52-Week Low, According to Wall Street
↗
March 22, 2025
Via
The Motley Fool
3 Growth Stocks Wall Street Might Be Sleeping On -- But I'm Not
↗
March 22, 2025
The time to buy quality prospects is when the rest of the market is ignoring their value.
Via
The Motley Fool
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
March 21, 2025
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
Down Nearly 80% From Its High, Is Iovance Biotherapeutics Stock Too Cheap to Pass Up?
↗
March 12, 2025
Via
The Motley Fool
These stocks are moving in today's after hours session
↗
February 27, 2025
The regular session of the US market on Thursday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
Via
Chartmill
Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Fourth Quarter and Full Year 2024
February 27, 2025
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
February 21, 2025
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
My 3 Favorite Stocks to Buy Right Now
↗
February 20, 2025
The market's underestimating how well each of these companies should be able to capitalize on their opportunities.
Via
The Motley Fool
Iovance Biotherapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates on February 27, 2025
February 18, 2025
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
February 12, 2025
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
Iovance Biotherapeutics Shares Fell Today: What's Going On?
↗
February 10, 2025
Iovance Biotherapeutics Inc. (NASDAQ: IOVA) shares closed lower on Monday potentially following the company's announcement of Dan Kirby as Chief Commercial Officer.
Via
Benzinga
Iovance Biotherapeutics Appoints Dan Kirby as Chief Commercial Officer
February 10, 2025
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
Meet the Growth Stock That Could Soar 280%, According to Wall Street Analysts
↗
January 27, 2025
Via
The Motley Fool
3 Stocks That Could Turn $1,000 Into $5,000 by 2030
↗
January 18, 2025
A handful of bullish factors are converging at the right time in the right way for all three of these companies.
Via
The Motley Fool
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
January 17, 2025
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
Iovance Biotherapeutics Shares Are Falling Today: What's Going On?
↗
January 10, 2025
Shares of Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) are trading lower Friday. The company announced the inducement stock option grants under Nasdaq Listing Rule 5635(c)(4).
Via
Benzinga
3 Mid-Cap Stocks That Could Take Off in 2025
↗
January 09, 2025
Via
The Motley Fool
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
22
23
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
